# The Effect of Tongguan Capsule for MicroRNA Profiles in Coronary Heart Disease Patients

Study · id `cardio:ct-nct02850627` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02850627](<https://clinicaltrials.gov/study/NCT02850627>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT02850627

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

## Technical summary

Registry record NCT02850627. Randomized; double masking; primary purpose prevention. Start 2016-07 (registry gives no type); primary completion 2017-09 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 100 participants (planned count; ClinicalTrials.gov record NCT02850627, source copy `cardio:ctgov-nct02850627-2016-08-02`, retrieved 2026-10-31)
- Start date: 2016-07 (registry gives no type) (ClinicalTrials.gov record NCT02850627, source copy `cardio:ctgov-nct02850627-2016-08-02`, retrieved 2026-10-31)
- Primary completion: 2017-09 (anticipated) (ClinicalTrials.gov record NCT02850627, source copy `cardio:ctgov-nct02850627-2016-08-02`, retrieved 2026-10-31)
- Completion: 2017-12 (anticipated) (ClinicalTrials.gov record NCT02850627, source copy `cardio:ctgov-nct02850627-2016-08-02`, retrieved 2026-10-31)
- Countries: China (ClinicalTrials.gov record NCT02850627, source copy `cardio:ctgov-nct02850627-2016-08-02`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02850627-2016-08-02`, retrieved 2026-10-31)

## The registry's words

- Brief title: The Effect of Tongguan Capsule for MicroRNA Profiles in Coronary Heart Disease Patients
- Condition: Coronary Heart Disease
- Condition: Acute Myocardial Infarction
- Intervention (Drug): Tongguan capsule
- Intervention (Drug): placebo capsule
- Lead sponsor: Guangdong Provincial Hospital of Traditional Chinese Medicine
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry lists this organization as the lead sponsor: Guangdong Provincial Hospital of Traditional Chinese Medicine (`cardio:org-guangdong-provincial-hospital-of-traditional-chinese-befb6a`)

## Provenance

Content hash: 7c13f3baa23808ad5d362eb3755b7e06580b5e5c771b10bf557bf9a4bf4aee85
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
